Managing irritable bowel syndrome (IBS): Is microbiome modulation the answer?
The understanding of the human microbiome continues to grow and this has immense potential for patients with IBS. Recognition and understanding of the influence of the gut-brain axis and gastrointestinal dysbiosis on symptomology of IBS may lead to new treatment strategies for patients experiencing this condition. This white paper presents a comprehensive overview of recent evidence for practitioners.

